DK130796B - Fremgangsmåde til fremstilling af et stabilt cellefrit viruspræparat. - Google Patents

Fremgangsmåde til fremstilling af et stabilt cellefrit viruspræparat.

Info

Publication number
DK130796B
DK130796B DK483171A DK483171A DK130796B DK 130796 B DK130796 B DK 130796B DK 483171 A DK483171 A DK 483171A DK 483171 A DK483171 A DK 483171A DK 130796 B DK130796 B DK 130796B
Authority
DK
Denmark
Prior art keywords
preparation
stable cell
free virus
virus preparation
free
Prior art date
Application number
DK483171A
Other languages
Danish (da)
English (en)
Other versions
DK130796C (fr
Inventor
B W Calnek
S B Hitchner
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK130796B publication Critical patent/DK130796B/da
Application granted granted Critical
Publication of DK130796C publication Critical patent/DK130796C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16351—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK483171A 1970-11-25 1971-10-05 Fremgangsmåde til fremstilling af et stabilt cellefrit viruspræparat. DK130796B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9292070A 1970-11-25 1970-11-25
US17061671A 1971-08-10 1971-08-10

Publications (2)

Publication Number Publication Date
DK130796B true DK130796B (da) 1975-04-14
DK130796C DK130796C (fr) 1975-10-06

Family

ID=26786189

Family Applications (1)

Application Number Title Priority Date Filing Date
DK483171A DK130796B (da) 1970-11-25 1971-10-05 Fremgangsmåde til fremstilling af et stabilt cellefrit viruspræparat.

Country Status (17)

Country Link
JP (1) JPS5750477B1 (fr)
AR (1) AR196979A1 (fr)
AU (1) AU473436B2 (fr)
BE (1) BE775747A (fr)
BR (1) BR7107679D0 (fr)
CA (1) CA935091A (fr)
CH (1) CH581193A5 (fr)
DE (1) DE2158293B2 (fr)
DK (1) DK130796B (fr)
FI (1) FI49522C (fr)
FR (1) FR2115379B1 (fr)
GB (1) GB1374123A (fr)
IE (1) IE35695B1 (fr)
IL (1) IL37849A (fr)
IT (1) IT1035519B (fr)
NL (1) NL7115348A (fr)
PH (1) PH11064A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT71926B (en) * 1979-10-29 1982-03-31 Merck & Co Inc Process for preparing a liquid vaccine comprising a stabilizer
GB2086408B (en) * 1980-10-16 1985-10-09 Oreal New nitro-derivatives of the benzene series the process for their preparation and their use in the dyeing of keratin fibres
ZA874625B (en) * 1986-06-30 1988-10-26 Smith Kline Rit Stabilizers for live vaccines,process for their preparation and vaccines containing them
JPS62212326A (ja) * 1987-09-14 1987-09-18 Gen Corp:Kk マレツク病２価生ワクチンとその製造方法

Also Published As

Publication number Publication date
IT1035519B (it) 1979-10-20
DE2158293A1 (de) 1972-06-08
CA935091A (en) 1973-10-09
FI49522C (fi) 1975-07-10
IL37849A (en) 1975-04-25
AR196979A1 (es) 1974-03-08
AU3442071A (en) 1973-04-19
JPS5750477B1 (fr) 1982-10-27
FR2115379A1 (fr) 1972-07-07
IL37849A0 (en) 1971-12-29
PH11064A (en) 1977-10-25
NL7115348A (fr) 1972-05-29
CH581193A5 (fr) 1976-10-29
DK130796C (fr) 1975-10-06
FR2115379B1 (fr) 1977-01-07
FI49522B (fr) 1975-04-01
DE2158293B2 (de) 1979-01-25
BR7107679D0 (pt) 1973-07-03
GB1374123A (en) 1974-11-13
AU473436B2 (en) 1976-06-24
IE35695L (en) 1972-05-25
IE35695B1 (en) 1976-04-28
BE775747A (fr) 1972-05-24

Similar Documents

Publication Publication Date Title
DK134316B (da) Fremgangsmåde til fremstilling af methylsubstituerede cuinoner.
DK132174B (da) Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimider.
DK129291B (da) Fremgangsmåde til fremstilling af et kimfattigt, flydedygtigt pancreatinpræparat.
DK129339B (da) Analogifremgangsmåde til fremstilling af N-aminophenylamidiner.
DK123357B (da) Analogifremgangsmåde til fremstilling af N(6)-benzyl-adenosin-derivater.
DK140842B (da) Fremgangsmåde til fremstilling af 8,9-didebydro-10alfa-alkoxy-ergolener.
DK130212B (da) Analogifremgangsmåde til fremstilling af 7-aminoindazolderivater.
DK134489B (da) Fremgangsmåde til fremstilling af alkyl-7-desoxy-7(S)-substituerede-alfa-thiolincosaminider.
DK128496B (da) Fremgangsmåde til fremstilling af 5-fluoruracilderivater.
DK130796B (da) Fremgangsmåde til fremstilling af et stabilt cellefrit viruspræparat.
DK130467B (da) Fremgangsmåde til fremstilling af erythromycylaminer.
DK128421B (da) Fremgangsmåde til fremstilling af en cellefri penicillinacylase.
DK127977B (da) Fremgangsmåde til fremstilling af 6α-methyl-19-nor-pregnener.
DK126998B (da) Analogifremgangsmåde til fremstilling af amino-s-triazolylbenzensulfonamidforbindelser.
DK127812B (da) Analogifremgangsmåde til fremstilling af 3,5-dibrom-zearalan.
DK133464B (da) Analogifremgangsmåde til fremstilling af nitrosourinstofderivater.
DK138021B (da) Fremgangsmåde til fremstilling af aminopenicilliner.
DK128205B (da) Fremgangsmåde til fremstilling af 1-aryloxy-2-propanoler.
DK129453B (da) Analogifremgangsmåde til fremstilling af 1-aminoisoquinoliner.
DK137181B (da) Analogifremgangsmåde til fremstilling af 3-amino-kinolinderivater.
DK125388B (da) Fremgangsmåde til fremstilling af phenylaminoethanolderivater.
DK137860B (da) Analogifremgangsmåde til fremstilling af triazolobenzodiazepin-5N-oxydderivater.
DK129138B (da) Fremgangsmåde til fremstilling af tuberactinomycin-N.
DK127852B (da) Analogifremgangsmåde til fremstilling af 22-substituerede cardenolidrhamnosider.
DK127414B (da) Analogifremgangsmåde til fremstilling af phenylhydrazider.